hSMG-1 inhibitor 11j, a pyrimidine derivative, is a potent and selective inhibitor of hSMG-1 , with an IC 50 of 0.11 nM. hSMG-1 inhibitor 11j exhibits >455-fold selectivity for hSMG-1 over mTOR ( IC 50 =50 nM), PI3Kα/γ ( IC 50 =92/60 nM) and CDK1/CDK2 ( I
Storage Temp
Store at 2-8°C,Protected from light,Desiccated
Shipped In
Wet ice
Product Description
hSMG-1 inhibitor 11j, a pyrimidine derivative, is a potent and selective inhibitor of hSMG-1 , with an IC 50 of 0.11 nM. hSMG-1 inhibitor 11j exhibits >455-fold selectivity for hSMG-1 over mTOR ( IC 50 =50 nM), PI3Kα/γ ( IC 50 =92/60 nM) and CDK1/CDK2 ( IC 50 =32/7.1 μM). hSMG-1 inhibitor 11j can be used for the research of cancer
In Vitro
hSMG-1 inhibitor 11j (0.3-3 μM; 6 h) significantly reduces UPF1 phosphorylation at 0.3 μM, and eliminates it at 1 μM in MDA 361 cells. hSMG-1 inhibitor 11j inhibits MDA468 cell proliferation, with an IC 50 of 75 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
